You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
李嘉誠基金會向劍橋、史丹福捐贈肝癌無創組織碎化治療儀器
阿思達克 06-17 17:16
李嘉誠基金會近日先後向英國劍橋大學及美國史丹福大學醫學院捐贈兩部革命性的「肝癌無創組織碎化治療」Histotripsy儀器,旨在加速尖端無創癌症治療技術的臨床應用,惠及更多病人。基金會表示,此標誌著其對全球頂尖醫療科研機構的長期承諾,和推動創新科技以改善人類健康的願景。 其中,英國劍橋大學將成為英國及全歐洲首家引入Histotripsy儀器的機構,該項技術預料將率先應用於劍橋大學醫院國民保健服務基金會信託旗下的愛丁布魯克醫院,預計將於今年夏季開始治療首批國民保健服務(NHS)的肝癌患者。 基金會董事周凱旋出席捐贈儀式時表示,李嘉誠收到不少香港病人的感謝信,病患們均表示他們的生活因Histotripsy的成功治療而得到改變,其正面影響立竿見影。周凱旋又引述李嘉誠常提到「救人一命勝造七級浮屠」,並表示有幸透過Histotripsy及相關創新科技幫助拯救生命,「每一個生命都如最宏偉的寶塔一樣彌足珍貴」。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account